The Human Correlation Core will serve to bridge the gap between mouse models and humans. This Core will analyze a number of the newly discovered murine immune regulatory genes using primary immune cells from normal human donors. The genes will be knocked down in primary human monocytes and in CD4, CDS and B-lymphocytes using lentivirus delivered shRNA. The cells will then be challenged with relevant NIAID category A, B and C priority pathogens or with purified immune agonists, as suggested by the murine studies. The effect of each gene on the production of cytokines and eicosanoids, on signaling pathways, and on global transcriptional responses will be measured using a variety of techniques in collaboration with the Systems Biology and CyTOF cores. In collaboration with the Bioinformatics Core, the effect of these genes on immune regulatory networks will be characterized. The Human Correlation Core will monitor the growing compendium of human variants in genes of unknown function that have been associated with infectious, immune, or inflammatory disease. Mice bearing ENU induced mutations in orthologs of these genes will be bred to homozygosity, thereby providing an animal model for determining the mechanism underlying the human disease.
Mice have traditionally been used as a model in which to study immune, infectious and inflammatory disease. However, our ultimate goal is to understand human diseases and to design therapies to combat them. This core will examine whether the disease mechanisms identified in mice are also applicable to humans.
|Wang, Ying; Su, Lijing; Morin, Matthew D et al. (2016) TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS. Proc Natl Acad Sci U S A 113:E884-93|
|Shi, Hexin; Wang, Ying; Li, Xiaohong et al. (2016) NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol 17:250-8|
|Siggs, Owen M; Stockenhuber, Alexander; Deobagkar-Lele, Mukta et al. (2016) Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity. Proc Natl Acad Sci U S A 113:E3706-15|
|Fragiadakis, Gabriela K; Baca, Quentin J; Gherardini, Pier Federico et al. (2016) Mapping the Fetomaternal Peripheral Immune System at Term Pregnancy. J Immunol 197:4482-4492|
|Wang, James Q; Beutler, Bruce; Goodnow, Christopher C et al. (2016) Inhibiting TLR9 and other UNC93B1-dependent TLRs paradoxically increases accumulation of MYD88L265P plasmablasts in vivo. Blood 128:1604-8|
|Andrews, T Daniel; Jeelall, Yogesh; Talaulikar, Dipti et al. (2016) DeepSNVMiner: a sequence analysis tool to detect emergent, rare mutations in subsets of cell populations. PeerJ 4:e2074|
|Angst, Martin S; Fragiadakis, Gabriela K; GaudilliÃ¨re, Brice et al. (2016) In Reply. Anesthesiology 124:1414-5|
|Parish, Ian A; Stamp, Lincon A; Lorenzo, Ayla May D et al. (2016) A Novel Mutation in Nucleoporin 35 Causes Murine Degenerative Colonic Smooth Muscle Myopathy. Am J Pathol 186:2254-61|
|Frei, Andreas P; Bava, Felice-Alessio; Zunder, Eli R et al. (2016) Highly multiplexed simultaneous detection of RNAs and proteins in single cells. Nat Methods 13:269-75|
|Wu, Zuopeng; Liang, Rong; Ohnesorg, Thomas et al. (2016) Heterogeneity of Human Neutrophil CD177 Expression Results from CD177P1 Pseudogene Conversion. PLoS Genet 12:e1006067|
Showing the most recent 10 out of 90 publications